OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Depletion of hypothalamic hypocretin/orexin neurons correlates with impaired memory in a Parkinson's disease animal model
Luíz M. Oliveira, Elisandra Henrique, Isabella B. Bustelli, et al.
Experimental Neurology (2019) Vol. 323, pp. 113110-113110
Closed Access | Times Cited: 14

Showing 14 citing articles:

Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19

Behavioral effects of 6-hydroxydopamine-induced damage to nigro-striatal pathway and Locus coeruleus as a rodent model of Parkinson’s disease
Isabella B. Bustelli, Luíz M. Oliveira, Nelson Francisco Correa-Netto, et al.
Behavioural Brain Research (2024) Vol. 462, pp. 114873-114873
Closed Access | Times Cited: 5

Role of Vitamin E and the Orexin System in Neuroprotection
Maria Ester La Torre, Ines Villano, Marcellino Monda, et al.
Brain Sciences (2021) Vol. 11, Iss. 8, pp. 1098-1098
Open Access | Times Cited: 26

Orexin and Parkinson's disease: A protective neuropeptide with therapeutic potential
Cui Liu, Yan Xue, Meifang Liu, et al.
Neurochemistry International (2020) Vol. 138, pp. 104754-104754
Closed Access | Times Cited: 25

The role of orexin in Parkinson's disease
Alisha Braun, Jim Manavis, Akihiro Yamanaka, et al.
Journal of Neuroscience Research (2024) Vol. 102, Iss. 3
Open Access | Times Cited: 2

Exploring the Role of Orexinergic Neurons in Parkinson’s Disease
Sachin Kumar, Tapan Behl, Aayush Sehgal, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 6, pp. 2141-2153
Closed Access | Times Cited: 12

Central Role of Hypothalamic Circuits for Acupuncture's Anti‐Parkinsonian Effects
Ju‐Young Oh, Hyowon Lee, S Jang, et al.
Advanced Science (2024) Vol. 11, Iss. 43
Open Access | Times Cited: 1

Hypocretin (Orexin) Replacement Therapies
Erica Seigneur, Luı́s de Lecea
Medicine in Drug Discovery (2020) Vol. 8, pp. 100070-100070
Open Access | Times Cited: 12

Experimental Models of Cognitive Impairment for Use in Parkinson’s Disease Research: The Distance Between Reality and Ideal
Yaohua Fan, Jiajun Han, Lijun Zhao, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 9

High-fat diet and related obesity provoke neurotoxins and alter neuro-biomarkers involved in Parkinson's disease
Nour Batarseh, Yazan Al Thaher
Obesity Medicine (2023) Vol. 41, pp. 100500-100500
Closed Access | Times Cited: 2

Banisteriopsis caapi extract: Implications for Neuroinflammatory Pathways in Locus coeruleus Lesion Rodent Model
Santhiago Calvelo Graça, Isabella B. Bustelli, Érica V Dos Santos, et al.
Journal of Ethnopharmacology (2024) Vol. 337, pp. 118775-118775
Closed Access

Hypothalamic orexins as possible therapeutic agents in threat and spatial memory disorders
Filip Mazur, Jarosław Całka
Frontiers in Behavioral Neuroscience (2023) Vol. 17
Open Access | Times Cited: 1

Traumatic and Degenerative Hypothalamic Diseases
Roger E. Kelley
Contemporary Endocrinology (2020), pp. 479-495
Closed Access

Page 1

Scroll to top